XWELL, Inc.
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 05 Dec 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Annual report filed late (NT 10-K)
The company filed Form NT 10-K with the SEC on 01 Apr 2026, notifying investors that its annual report would be late. A late annual report can point to accounting or audit problems, though the reason is sometimes routine.
More details →Quarterly report filed late (NT 10-Q)
The company filed Form NT 10-Q with the SEC on 15 May 2026, notifying investors that its quarterly report would be late. Late filings can point to accounting or business problems, though the reason is sometimes routine.
More details →XWELL, Inc. — Overview & Financial Snapshot
XWELL, Inc. (NasdaqCM: XWEL) is a Healthcare company, ranked #6,499 of 6,774 companies globally and #3,749 of 4,000 in United States on PositoAI, with a Positivity Score of -21,728. Its market capitalisation is ₹64.34 Cr ($6.82M), P/E ratio is -0.1 and P/B ratio is -3.68. It currently has 1 active red flag (PosiRed) and 2 yellow flags (PosiYellow, 6/10 points) on record.
For financial statements, ratio trends and score history, Go Deep →